TVARDI THERAPEUTICS, INC. Debt Securities, Available-for-sale, Noncurrent
TVARDI THERAPEUTICS, INC. (TVRD) had Debt Securities, Available-for-sale, Noncurrent of $47.17 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2022-08-08
- 2022-06-30: Debt Securities, Available-for-sale, Noncurrent $47.17M.
- 2022-03-31: Debt Securities, Available-for-sale, Noncurrent $68.46M.
- 2021-12-31: Debt Securities, Available-for-sale, Noncurrent $69.75M.
- 2021-09-30: Debt Securities, Available-for-sale, Noncurrent $49.22M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2022-06-30 | $47.17M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $68.46M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $69.75M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $49.22M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $52.22M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $56.73M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $70.56M 10-K · filed 2022-03-01 |
| 2020-09-30 | $10.51M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $22.86M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $59.57M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $63.16M 10-K · filed 2021-02-25 |
| 2019-09-30 | $55.98M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $20.32M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $21.69M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $21.40M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |